Myelofibrosis and Polycythemia Vera: Integrating Recent Advances Into Clinical Practice

Review an on-demand Webcast, downloadable slides, and expert question and answer modules on new data and best practices for the optimal management of myelofibrosis and polycythemia vera.
Brady L. Stein, MD, MHS
Program Director
Srdan Verstovsek, MD, PhD
Program Director
person default
John Mascarenhas, MD
Stephen Oh, MD, PhD
person default
Nikolai Podoltsev, MD, PhD
Raajit K. Rampal, MD, PhD
Michael J. Savona, MD
person default
David S. Snyder, MD

FAQ Modules

In this activity, experts answer frequently asked questions from a live meeting series regarding the management of myelofibrosis and polycythemia vera, including diagnosis, treatment, patient monitoring, and adverse events.

Brady L. Stein, MD, MHS
Program Director
Srdan Verstovsek, MD, PhD
Program Director
person default John Mascarenhas, MD Stephen Oh, MD, PhD Raajit K. Rampal, MD, PhD Michael J. Savona, MD person default David S. Snyder, MD
Released: March 5, 2018

In this activity, experts answer frequently asked questions from a live meeting series regarding the management of myelofibrosis and polycythemia vera, including clinical challenges in both diagnosis and treatment.

Brady L. Stein, MD, MHS
Program Director
Srdan Verstovsek, MD, PhD
Program Director
Stephen Oh, MD, PhD person default Nikolai Podoltsev, MD, PhD Raajit K. Rampal, MD, PhD
Released: June 7, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an educational grant from
Incyte

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue